Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 5

Hyperthyroidism and oral warfarin: A case report

Hipertroidi ve warfarin: Vaka takdimi

Pages
340–341
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

So we aimed to present a patient with hyperthyroidism admitted with severe hemorrhage just after the warfarin usage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Warfarin is a drug which is widely used to prevent the thromboembolic events.
📊
Key Findings & Data:Thus effect of warfarin can either be decreased or significantly increased.
💡
Conclusion & Impact:So we aimed to present a patient with hyperthyroidism admitted with severe hemorrhage just after the warfarin usage.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Protrombin zamanı · Atriyal fibrilasyon · Ekokardiyografi

Abstract

Warfarin is a drug which is widely used to prevent the thromboembolic events. But it easily interacts with both drugs and various foods. Thus effect of warfarin can either be decreased or significantly increased. Warfarin also interacts with thyroid hormones, metabolically. So we aimed to present a patient with hyperthyroidism admitted with severe hemorrhage just after the warfarin usage.

Özet

Warfarin, tromboembolik olayları önlemede yaygın olarak kullanılan bir ilaçtır. Ancak hem ilaçlarla ve hem de yiyeceklerle kolaylıkla etkileşime girebilmekte, böylece ya etkisi azalmakta veya belirgin olarak artabilmektedir. Tiroid hormonları ile de etkileşime girebilmektedir. Bu yazımızda atrial fibrilasyon nedeniyle warfarin başlanmasından kısa süre sonra yaygın kanamalar ile başvuran hipertroidili bir hastamızı literatür bilgileri ışığında sunmayı uygun bulduk.

🔖

Cite This Article

ÖZMEN, N., CİNGÖZBAY, B. Y., APARCI, M., GÜL, M., ATALAY, M., TUNÇ, E., TOKATLI, A., ERİKÇİ, A., DİNÇTÜRK, M. (2006). Hyperthyroidism and oral warfarin: A case report. MN Kardiyoloji, Cilt: 13 - Sayı: 5, 340–341. https://ajindex.com/articles/297836

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Levy S, Camm AJ, Saksena S, et al. Intemational consensus on nomenclature and classification of atrial fibrillation. Europace 2003; 5:119-22
  2. Fadel BM, Ellahham S, Ringel MD, Lindsay J, Jr, Wartofsky L, Burman KD. Hyperthyroid heart disease. Clin Cardiol 2000; 23:402-8
  3. Adalet K, Karaoğuz R, Mercanoğlu F, Oto A, et al. Türk Kardiyoloji Demeği Atrial fibrilasyon tanı ve tedavi kılavuzu. Türk Kardiyol Dern Arş 2003; 31:737-62
  4. Busenbark LA, Cushnie SA. Effect of Graves' disease and methimazole on warfarin anticoagulation. Ann Pharmacother 2006; 40:1200-3
  5. Chute JP, Ryan CP, Sladek G, Shakir KM. Exarbation of warfarin-induced anticoagulation by hyperthyroidism. Endocr Pract 1997; 3:77-9